Lightning Round: I don't have a positive outlook on Sarepta, says Jim Cramer

Key Concepts

• AI and Data Center Components
• Internet of Things (IoT)
• Stock Valuation
• Averaging Down
• Drone Technology
• Defense Spending
• Inflation Clues

Stock Analysis and Recommendations

T Connectivity (TEL)

• Caller's Question: Steve from New Jersey inquired about T Connectivity, a company manufacturing connecting components for AI and data centers. The stock has a P/E ratio of 24.36 and pays a dividend of $0.71 per share. The company also reported key earnings and revenue last quarter.
• Jim Cramer's Opinion: Cramer views T Connectivity as an "excellent company" and favors the Internet of Things (IoT) sector. He believes it is performing better than Analog Devices.

Bit Mine

• Caller's Question: Jim from Pennsylvania asked if Bit Mine is still a buy, considering its recent price increase.
• Jim Cramer's Opinion: Cramer advises against buying Bit Mine. He references a long piece by his colleague David Faber regarding the stock's real value and outstanding shares, implying an overvaluation. He explicitly states, "you don't want to touch it."

Webull Trading (BULL)

• Caller's Question: Sarah from South Carolina inquired about the stock ticker BULL, representing Webull trading.
• Jim Cramer's Opinion: Cramer states that if one wants to invest in that sector, Coinbase is a preferred option. While he won't discourage investing in Webull, he suggests Coinbase as a stronger alternative.

Direct Therapeutic

• Caller's Question: Christine from California, a first-time caller, sought advice on Direct Therapeutic stock, which she purchased over a year ago at around $133. The stock has since declined significantly, and she has been averaging down. She asked for Cramer's outlook and strategy.
• Jim Cramer's Opinion: Cramer expresses a negative outlook on Direct Therapeutic. He compares it unfavorably to Sarepta, stating that he doesn't believe Direct Therapeutic has the potential to grow significantly beyond its current state. He advises selling if the stock price increases.

Kratos Defense and Security Solutions

• Caller's Question: Jonathan from New Jersey inquired about Kratos Defense and Security Solutions, a drone company, given the increased global defense spending.
• Jim Cramer's Opinion: While acknowledging the appeal of drone companies, Cramer prefers AbbVie. He states, "I'm going to stick with my AbbVie."

Lightning Round Sponsor

• The Lightning Round is sponsored by Charles Schwab.

Upcoming Segment

• The next segment will focus on the Producer Price Index (PPI) and its implications for the Federal Reserve's policies. Cramer will analyze inflation clues that investors may have overlooked.

Squawk on the Street

• Tomorrow's "Squawk on the Street" will be broadcast live from Post 9 at the New York Stock Exchange (NYSE).

Reagan Theory

• Cramer mentions the "Reagan theory," referencing the movie "The Exorcist" and not the former president. This is used metaphorically to describe a volatile or unpredictable market situation.

Conclusion

The Lightning Round featured a mix of opinions on various stocks, ranging from positive views on T Connectivity to negative outlooks on Bit Mine and Direct Therapeutic. Cramer emphasized the importance of careful stock selection and understanding the underlying value of companies. He also highlighted the significance of upcoming economic data, such as the PPI, in shaping market sentiment.